OVARIAN-CARCINOMA - A REVIEW OF THE SIGNIFICANCE OF FAMILIAL RISK-FACTORS AND THE ROLE OF PROPHYLACTIC OOPHORECTOMY IN CANCER PREVENTION

被引:0
|
作者
NGUYEN, HN [1 ]
AVERETTE, HE [1 ]
JANICEK, M [1 ]
机构
[1] DIV GYNECOL ONCOL, MIAMI, FL USA
关键词
OVARIAN CANCER; FAMILY HISTORY; HEREDITARY CANCER SYNDROME; PROPHYLACTIC OOPHORECTOMY;
D O I
10.1002/1097-0142(19940715)74:2<545::AID-CNCR2820740204>3.0.CO;2-Q
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Women with a family history of ovarian cancer are at increased risk of ovarian cancer. Prophylactic oophorectomy(PO) remains the only effective method of ovarian cancer prevention. This study reviewed current data on the significance of family history and how prophylactic oophorectomy should be used in different risk groups. Approximately 7% of ovarian cancer patients have a positive family history of whom 3-9% may eventually manifest certain hereditary cancer syndromes. Women in direct genetic lineage of family cancer syndromes have up to a 50% lifetime risk of ovarian cancer. Because of the high risk, PO is indicated for women with familial cancer syndromes after childbearing or between the ages of 35-40 at the latest. The majority of women with a positive family history of ovarian cancer do not have one of the recognized syndromes. Women with one or two affected relatives have an increased lifetime risk of ovarian cancer from a baseline of 1.6 to 5-7%. This risk is not high enough to warrant PO for a large number of women. After being properly informed, the patient still chooses surgical prevention, she then receives PO. For women without a family history of ovarian cancer, the role of PO remains controversial. Assuming an annual incidence of 22,000 new cases of ovarian cancer, it is estimated that at least 1000 may be prevented if PO is diligently practiced during hysterectomy. Despite ovarian and breast cancer prevention, PO would lead to shorter life expectancy if estrogen therapy compliance were less than perfect. Thus, the decision on PO as a concurrent procedure should depend on the individual patient and her ability to comply with lifelong estrogen therapy.
引用
收藏
页码:545 / 555
页数:11
相关论文
共 50 条
  • [41] Outcome of surveillance and prophylactic salpingo-oophorectomy in asymptomatic women at high risk for ovarian cancer
    Meeuwissen, PAM
    Seynaeve, C
    Brekelmans, CTM
    Meijers-Heijboer, HJ
    Klijn, JGM
    Burger, CW
    GYNECOLOGIC ONCOLOGY, 2005, 97 (02) : 476 - 482
  • [42] Psychological impact of prophylactic oophorectomy in women at increased risk of developing ovarian cancer: A prospective study
    Tiller, K
    Meiser, B
    Butow, P
    Clifton, M
    Thewes, B
    Friedlander, M
    Tucker, K
    GYNECOLOGIC ONCOLOGY, 2002, 86 (02) : 212 - 219
  • [43] RISK-FACTORS IN CERVICAL-CANCER AND THEIR KNOWLEDGE IN PREVENTION
    PEJOVIC, MH
    THUAIRE, M
    CONTRACEPTION FERTILITE SEXUALITE, 1983, 11 (03): : 391 - 400
  • [44] RISK-FACTORS AND THE PREVENTION OF BREAST-CANCER WITH TAMOXIFEN
    MORROW, M
    JORDAN, VC
    CANCER SURVEYS, 1993, 18 : 211 - 229
  • [45] INTERACTION OF FAMILIAL AND HORMONAL RISK-FACTORS FOR BREAST-CANCER
    BRINTON, LA
    HOOVER, R
    FRAUMENI, JF
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1982, 69 (04): : 817 - 822
  • [46] The role of peritoneal cytology at risk-reducing salpingo-oophorectomy (RRSO) in women at increased risk of familial ovarian/tubal cancer
    Manchanda, Ranjit
    Drapkin, Ronny
    Jacobs, Ian
    Menon, Usha
    GYNECOLOGIC ONCOLOGY, 2012, 124 (02) : 185 - 191
  • [47] Factors influencing uptake and timing of risk reducing salpingo-oophorectomy in women at risk of familial ovarian cancer: a competing risk time to event analysis
    Manchanda, R.
    Burnell, M.
    Abdelraheim, A.
    Johnson, M.
    Sharma, A.
    Benjamin, E.
    Brunell, C.
    Saridogan, E.
    Gessler, S.
    Oram, D.
    Side, L.
    Rosenthal, A. N.
    Jacobs, I.
    Menon, U.
    BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2012, 119 (05) : 527 - 536
  • [48] ISOLATION AND PRELIMINARY CHARACTERIZATION OF AN OVARIAN-CARCINOMA CELL-LINE FROM A PATIENT WITH FAMILIAL OVARIAN-CANCER
    BULLER, RE
    NIEMANN, T
    CONNOR, JP
    SQUATRITO, RC
    SKILLING, JS
    ANDERSON, B
    GYNECOLOGIC ONCOLOGY, 1995, 56 (01) : 39 - 44
  • [49] An investigation on the completeness of prophylactic salpingectomy intended for the prevention of ovarian cancer risk
    Wong, J. W. H.
    Killeen, J. L.
    Carney, M. E.
    GYNECOLOGIC ONCOLOGY, 2019, 154 : 230 - 230
  • [50] Prophylactic salpingo-oophorectomy in 51 women with familial breast-ovarian cancer: importance of fallopian tube dysplasia
    Leunen, K
    Legiusy, E
    Moerman, P
    Amant, F
    Neven, P
    Vergote, I
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2006, 16 (01) : 183 - 188